Professor Ji-Guang Wang has spent his career treating and researching hypertension in China, where rates have risen from 10% to 30% in the past three decades.

The prevalence of hypertension is 22.7 percent among young adults aged 18 to 39 years and 5.4 percent among youth aged 8 to 19 years.

Colonic manifestations of portal hypertension include enlarged hemorrhoids, rectal varices and endoscopic features of diffuse vascular ectasia. The frequency of at least one of these features in ...

The Clinical Trials Program at Sidra Medicine will focus on clinical trials that will benefit children in the Arab region, particularly those withrare diseases that lack effective treatment.This ...

18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on ... target for treating HCC. Clinical data with irpagratinib ...

"An antibiotic allergy label has a significant impact on the clinical care of children that come into hospital, and this is exacerbated when the child comes in under the microbial stewardship ...

The poster, #983P, was presented at the Hepatocellular ... The FGFR4 signaling pathway is a recognized and promising target for treating HCC. Clinical data with irpagratinib have demonstrated ...

SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for ...

18, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16 ... recognized and promising target for treating HCC.

SHANGHAI, Sept. 19, 2024 /PRNewswire/ -- Abbisko Therapeutics (HKEX: 02256) is excited to announce the receipt of the ESMO 2024 Best Poster Award on September 16, 2024. The award was received for the ...